135 related articles for article (PubMed ID: 15331546)
1. Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients.
Rudovich NN; Rochlitz HJ; Pfeiffer AF
Diabetes; 2004 Sep; 53(9):2359-65. PubMed ID: 15331546
[TBL] [Abstract][Full Text] [Related]
2. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
[TBL] [Abstract][Full Text] [Related]
3. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS; Ryan AS; Minaker KL; Elahi D
J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
[TBL] [Abstract][Full Text] [Related]
4. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
6. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine.
Rudovich NN; Dick D; Moehlig M; Otto B; Spranger J; Rochlitz HJ; Ristow M; Tschoep M; Pfeiffer AF
Regul Pept; 2005 Apr; 127(1-3):95-9. PubMed ID: 15680475
[TBL] [Abstract][Full Text] [Related]
8. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.
Meier JJ; Gallwitz B; Kask B; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetes; 2004 Dec; 53 Suppl 3():S220-4. PubMed ID: 15561915
[TBL] [Abstract][Full Text] [Related]
10. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
11. Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance.
Eriksen M; Jensen DH; Tribler S; Holst JJ; Madsbad S; Krarup T
Diabetologia; 2015 May; 58(5):920-8. PubMed ID: 25748606
[TBL] [Abstract][Full Text] [Related]
12. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
13. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
14. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
Meier JJ; Hücking K; Holst JJ; Deacon CF; Schmiegel WH; Nauck MA
Diabetes; 2001 Nov; 50(11):2497-504. PubMed ID: 11679427
[TBL] [Abstract][Full Text] [Related]
15. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
Fritsche A; Stefan N; Hardt E; Schützenauer S; Häring H; Stumvoll M
Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901
[TBL] [Abstract][Full Text] [Related]
16. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
[TBL] [Abstract][Full Text] [Related]
17. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
18. Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
Veedfald S; Vedtofte L; Skov-Jeppesen K; Deacon CF; Hartmann B; Vilsbøll T; Knop FK; Christensen MB; Holst JJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665480
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients.
Pimenta WP; Santos ML; Cruz NS; Aragon FF; Padovani CR; Gerich JE
Braz J Med Biol Res; 2003 Mar; 36(3):301-8. PubMed ID: 12640493
[TBL] [Abstract][Full Text] [Related]
20. Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes.
Boden G; Chen X; Polansky M
Diabetes; 1999 Nov; 48(11):2182-8. PubMed ID: 10535452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
